Rchr
J-GLOBAL ID:201901014198293500   Update date: Apr. 14, 2024

Kitamura Yohei

Kitamura Yohei
Affiliation and department:
Research theme for competitive and other funds  (6):
  • 2024 - 2027 固形癌の癌性髄膜炎に対する幹細胞治療の構築
  • 2021 - 2024 乳癌の脳微小転移および髄膜播種に対する幹細胞治療の有効性の検討
  • 2015 - 2018 Towards personalized treatment of diffuse gliomas based on molecular characteristics
  • 2014 - 2016 Genetic characterization of skull base chondrosarcoma and chordoma
  • 2012 - 2014 Molecular risk factors of skull base chordomas
Show all
Papers (32):
  • Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain tumor pathology. 2024
  • Kosuke Karatsu, Ryota Tamura, Masahiro Yo, Hirotsugu Nogawa, Utaro Hino, Yohei Kitamura Ryo Ueda, Masahiro Toda. The Role of Genetic Analysis in Distinguishing Multifocal and Multicentric Glioblastomas: An Illustrative Case. Case Reports in Oncology. 2024. 17. 113-121
  • Susana Moleirinho, Yohei Kitamura, Paulo S G N Borges, Sophia Auduong, Seyda Kilic, David Deng, Nobuhiko Kanaya, David Kozono, Jing Zhou, Jeffrey J Gray, et al. Fate and efficacy of engineered allogeneic stem cells targeting cell death and proliferation pathways in primary and brain metastatic lung cancer. Stem Cells Translational Medicine. 2023
  • Nobuhiko Kanaya, Yohei Kitamura, Maria Lopez Vazquez, Arnaldo Franco, Kok-Siong Chen, Thijs A van Schaik, Touraj Aligholipour Farzani, Paulo Borges, Toru Ichinose, Waleed Seddiq, et al. Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas. Science Translational Medicine. 2023. 15. 698. eade8732
  • Yohei Kitamura, Masahiro Toda. [Medical Treatments for Malignant Brain Tumor]. Brain and nerve = Shinkei kenkyu no shinpo. 2023. 75. 5. 561-566
more...
MISC (24):
  • Hikaru Sasaki, Tokunori Kanazawa, Yohei Kitamura, Masato Nakaya, Hirokazu Fujiwara, Tokuhiro Kimura, Shunsuke Nakae, Shigeo Ohba, Yuya Nishiyama, Masahiro Toda, et al. LW-8 TREATMENT STRATEGY FOR OLIGODENDROGLIOMAS WITH NEOADJUVANT STRATEGY AND STAGED RESECTION UTILIZING THEIR CHEMOTHERAPEUTIC RESPONSIVENESS. Neuro-Oncology Advances. 2022. 4. Supplement_3. iii27-iii27
  • 今井 亮太郎, 今井 光穂, 北村 洋平, 川井田 みほ, 辻川 華子, 佐々木 光. 薬物治療および放射線治療に抵抗性を示した膠芽腫の一例. Brain Tumor Pathology. 2022. 39. Suppl. 089-089
  • Yohei Kitamura, Susana Moleirinho, Nobuhiko Kanaya, Arnaldo Franco, Khalid Shah. DEVELOPING CLINICALLY RELEVANT BRAIN METASTATIC TUMOR MODELS FOR TARGETED STEM CELL THERAPEUTICS. NEURO-ONCOLOGY. 2020. 22. 227-227
  • 山田 哲, 岩本 創哉, 成田 秀文, 北村 洋平, 大木 宏一, 星野 晴彦. 症候性頭蓋内内頸動脈狭窄症に対するWingspan stentの治療成績. 脳血管内治療. 2020. 5. Suppl. 101-101
  • 山田 哲, 岩本 創哉, 成田 秀文, 北村 洋平, 大木 宏一, 星野 晴彦. ステント併用コイル塞栓術後に再増大した椎骨動脈解離性動脈瘤に対するLVIS stentの有用性. 脳血管内治療. 2020. 5. Suppl. 115-115
more...
Professional career (1):
  • 博士(医学) (慶應義塾大学)
Work history (6):
  • 2022/04 - 慶應義塾大学医学部 脳神経外科 助教
  • 2019/08 - Tokyo Saiseikai Central Hospital Department of Neurosurgery Attending
  • 2017/01 - Brigham and Women's Hospital, Harvard Medical School Department of Neurosurgery Research Fellow
  • 2016/08 - Massachusetts General Hospital, Harvard Medical School Department of Radiology Research Fellow
  • 2013/04 - Saiseikai Utsunomiya Hospital Department of Neurosurgery Attending
Show all
Awards (1):
  • 2021/12 - Japanese Society of Neuro-Oncology Hoshino Prize
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page